baber/WOPTO huggingface dataset:
Patent NZ-582694-A (NZ)
Title: Glazed transit vehicle door or window with first and second frames secured together by U-shaped clips, window pane adhesively bonded to the second frame.
Inventor: GRIFFIS DAVID C
IPC: B60J5/04
Filed: 2009-04-01
Abstract: A transit vehicle glazing assembly comprises a window pane (22), a box-shaped first frame (18) that surrounds the opening covered by the window pane and a second frame (20) sized to fit within the space enclosed by the first frame. The first frame has a flange (28) extending into the opening spaced from the interior surface (24) of the window pane (22) and has a detent (30) facing away from the window pane. The second frame (20) forms a channel with a first leg (32) secured to the window pane by an adhesive and a second leg (36) spaced from and parallel to the flange (28) having a detent (34) facing towards the window. An elastomeric strip (38) is positioned in the space between the flange (28) and the second leg (36) and a plurality of U-shaped clips (42) secure the second frame (20) to the first frame (18).
Patent NZ-583555-A (NZ)
Title: Photocatalytic paint containing anatase, pigments, and a styrene acrylic copolymer binder
Inventor: MALTBY JULIE ELIZABETH
IPC: C09D7/61
Filed: 2008-08-29
Abstract: Disclosed is a self-cleaning, de-polluting paint comprising: (i) from about 5% to about 40% by volume photocatalytic titanium dioxide in substantially pure anatase form, which has an average crystallite size between about 5 nm and about 30 nm and has photocatalytic activity in the presence of visible light; (ii) one or more additional pigments, such that the total pigment volume concentration of said paint, inclusive of said photocatalytic titanium dioxide, is at least about 65%; and (iii) a styrene acrylic copolymer binder. This paint is capable of substantially reducing NOx compounds immediately after a dried coating of said paint is formed on a substrate, in the absence of prior activation with water.
Patent NZ-584474-A (NZ)
Title: Amides useful as inhibitors of voltage-gated sodium channels
Inventor: CHEN WEICHUAN CAROLINE
IPC: A61K31/33
Filed: 2008-10-10
Abstract: Disclosed are amide compounds represented by general formula (I). An example of a compound of formula (I) is 4-tert-Butyl-N-(5-(methylsulfonyl)pyridin-3-yl)-2-(6-trifluoromethyl)pyridin-3-yloxy)benzamide. The compounds of formula (I) are used to treat acute, chronic, neuropathic, or inflammatory pain, arthritis, migraine, cluster headaches, trigeminal neuralgia, herpetic neuralgia, general neuralgias, epilepsy or epilepsy conditions, neurodegenerative disorders, psychiatric disorders such as anxiety and depression, dipolar disorder, myotonia, arrhythmia, movement disorders, neuroendocrine disorders, ataxia, multiple sclerosis, irritable bowel syndrome, incontinence, visceral pain, osteoarthritis pain, postherpetic neuralgia, diabetic neuropathy, radicular pain, sciatica, back pain, head or neck pain, severe or intractable pain, nociceptive pain, breakthrough pain, postsurgical pain, cancer pain, stroke, cerebral ischemia, traumatic brain injury, amyotrophic lateral sclerosis, stress- or exercise induced angina, palpitations, hypertension, migraine, or abnormal gastro-intestinal motility.
Patent NZ-585530-A (NZ)
Title: Methods for differentiating plasma-derived protein from recombinant protein in a sample
Inventor: WEBER ALFRED
IPC: G01N33/50
Filed: 2008-12-22
Abstract: Disclosed is a method to quantitate the amount of plasma-derived protein (PdP) and recombinant protein (rP) in a sample from an individual, wherein the plasma-derived protein and recombinant protein are the same protein with different glycosylation patterns, said different glycosylation patterns giving rise to different degrees of lectin binding for the plasma-derived protein compared to the recombinant protein, wherein total protein (tP) in said sample is predetermined and equal to the amount of plasma-derived protein and recombinant protein (pdP+rP), said method comprising the steps of: (a) contacting the sample with a lectin composition and detecting protein binding to the lectin composition; and (b) calculating a difference between lectin binding for said sample from said individual and expected lectin binding for a second sample of equal volume having an amount of plasma-derived protein equal to total protein (tP), wherein the difference is proportional to the amount of recombinant protein in the sample from the individuals.
Patent NZ-590016-A (NZ)
Title: An electrolytic cell comprising at least two electrodes and at least one insulating layer with perforations
Inventor: LANGDON ALAN GEORGE
IPC: C25B9/17
Filed: 2010-12-17
Abstract: Disclosed is an electrolytic cell (100) including at least two electrodes (101, 103), each electrode (101, 103) including a first and a second surface and a number of perforations. The electrodes (101, 103) are positioned relative to each other such that at least one surface of each electrode (101, 103) is opposed to a surface of the other electrode (101, 103), and a gap (104) is formed between the opposed surfaces of the electrodes (101, 103). At least one electrically insulating layer (102) is positioned on the opposing surface of one of the electrodes (101), the insulating layer (102) including a number of perforations (106) aligning with the perforations (106) of the electrode (101) on which it is positioned. The thickness of the insulating layer (102) is less than the distance between the opposed surfaces of the electrodes (101, 103). The cell (101) is configured such that fluid flow is directed through the perforations of one electrode (103), between the insulating layer (102) and the surface of the electrode (103) opposed to the surface on which the insulating layer (102) is positioned, and through the perforations (106) of the other electrode (101).
Patent NZ-591745-A (NZ)
Title: Improved compositions and processes for paper production
Inventor: BROADUS KATHERINE M
IPC: D21H21/00
Filed: 2007-07-19
Abstract: Disclosed herein is a method of making a paper product having enhanced brightness and resistance to thermal yellowing comprising: i) providing bleached pulp; ii) forming an aqueous stock suspension to form a sheet; iii) draining the stock suspension to form a sheet; iv) drying the sheet; and v) treating the bleached pulp, the stock suspension or the sheet with one or more oxidizing agents, said treating with one or more oxidizing agents consisting of essentially of: a) adding an effective amount of one or more oxidizing agents including organic peroxyacids onto the sheet, wherein the oxidizing agents are slected from the group consisting of hydrogen peroxide, inorganic peroxides, superoxides and peroxide0superoxides, inorganic peroxyacids and salts thereof, peroxyhydrates, water-soluble organic peroxides, nirtosodisulfonates, hypochlorites, hypobromites, chlorites, chlorates, bromates, perchlorates, chlorine dioxide, chloroamines, chloroamides, chlorosulfamides, bromoamines, bromoamides, bromosulfamides, chlorosulfonic acid, bromosulfonic acid and chlorine.
Patent NZ-593473-A (NZ)
Title: Sulfonamide derivatives
Inventor: BEAUDOIN SERGE
IPC: C07D275/03
Filed: 2010-01-06
Abstract: 593473 SULFONAMIDE DERIVATIVES This disclosure relates to sulfonamide derivatives. More particularly, this invention relates to heteroaryl substituted sulphonamide derivatives and to processes for the preparation of, intermediates used in the preparation of, compositions containing, and the uses of, such derivatives. The sulfonamide derivatives of the disclosure are sodium channel modulators and have a number of therapeutic applications, particularly in the treatment of pain. Compounds of the disclosure include: 4-[2-( 6-aminopyridin-3-yl)-4-fluorophenoxy]-N-(5-chloro-1,3-thiazol-2-yl)-3-cyanobenzenesulfonamide; N-(5-chloro-1,3-thiazoI-2-yI)-3-cyano-4-[4-fluoro-2-(1H-pyrazol-4-yl)phenoxy]benzenesulfonamide; 2,5-difluoro-4-[2-(1H-pyrazol-5-yl)-4-(trifluoromethyl)phenoxy]-N-1,2,4-thiadiazol-5-ylbenzenesulfonamide; 4-[2-(5-amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-1,3,4-thiadiazol-2-ylbenzenesulfonamide; 4-[2-(3-amino-1H-pyrazol-4-yl)-4-(trifluoromethyl)phenoxy]-5-chloro-2-fluoro-N-1,3-thiazol-4-ylbenzenesulfonamide and 2-fluoro-5-methyl-4-[2-pyridazin-4-yl-4-(trifluoromethoxy)phenoxy]-N-1,3,4-thiadiazol-2-ylbenzenesulfonamide.
Patent NZ-594191-A (NZ)
Title: Expandable casing with enhanced collapse resistance and sealing capability with longitudinally spaced grooves in casing
Inventor: WATSON BROCK W
IPC: E21B43/10
Filed: 2010-02-12
Abstract: An expandable casing has enhanced collapse resistance and sealing capability. An expandable tubular is disclosed for use in a subterranean well and includes multiple recesses extending into a wall of the tubular, with the recesses being longitudinally spaced apart along the wall. A method of expanding tubulars in a subterranean well includes the steps of: expanding a tubular in the well, the tubular including multiple recesses extending into a wall of the tubular; and after the expanding step, allowing the wall of the tubular to retract radially inward more at each of the recesses than between the recesses.
Patent NZ-597067-A (NZ)
Title: Monoclonal antibodies expressed by ATCC PTA-4621 for the treatment of cancer
Inventor: YOUNG DAVID S F
IPC: C12P21/08
Filed: 2008-05-23
Abstract: Disclosed is the use of a humanized antibody comprising: a heavy chain variable region comprising the complementarity determining region amino acid sequences of SEQ ID NO: 1, SEQ ID NO:2, and SEQ ID NO:3; and a light chain variable region comprising the complementarity determining region amino acid sequences of SEQ ID NO:4, SEQ ID NO:5, or SEQ ID NO:6; or a human CD44 binding fragment thereof; wherein said humanized antibody specifically binds the same epitope or epitopes of human CD44 as the isolated monoclonal antibody produced by the hybridoma cell line H460-16-2 having ATCC Accession No. PTA-4621; in the preparation of a medicament for use in treatment of a human pancreatic, ovarian, or colon tumor, wherein said tumor expresses at least one epitope of an antigen which specifically binds to the isolated monoclonal antibody produced by the hybridoma cell line deposited with the ATCC as accession number PTA-4621 or a CDMAB (cancerous disease modifying antibody) thereof, which CDMAB is characterized by an ability to competitively inhibit binding of said isolated monoclonal antibody to its target antigen.
Patent NZ-599978-A (NZ)
Title: Use of at least one microorganism belonging to the species aureobasidium pullulans as a fermentation aid for fruits
Inventor: DONAT CHRISTINA
IPC: C12G1/02
Filed: 2010-11-19
Abstract: NZ 599978 Disclosed is the use of at least one microorganism belonging to the species Aureobasidium pullulans and selected from Aureobasidium pullulans DSM 14940 or Aureobasidium pullulans DSM 14941 as a fermentation aid for fruits.
Patent NZ-601173-A (NZ)
Title: Magnetite in nanoparticulate form
Inventor: BITOSSI MARCO
IPC: A61K33/26
Filed: 2010-12-15
Abstract: 601173 The disclosure relates to a process for the polyol-type synthesis of nanoparticulate magnetite starting from mixtures of Fe0 and Fe1III in the presence of a mineral acid. The magnetite particles obtainable from the process have uniform size characteristics and have even presented higher SAR (Specific Absorption Rate) values than those of magnetosomes.
Patent NZ-604805-A (NZ)
Title: Polypeptides
Inventor: Abrahmsén Lars
IPC: C07K14/195
Filed: 2011-07-08
Abstract: Discloses albumin binding polypeptides comprising an amino acid sequence selected from i) LAX3AKX6X7ANX10ELDX14YGVSDFYKRLIX26KAKTVEGVEALKX39X40ILX43X44LP X3 is selected from E, S, Q and C; X6 is selected from E, S and C; X7 is selected from A and S; X10 is selected from A, S and R; X14 is selected from 15 A, S, C and K; X26 is selected from D and E; X39 is selected from D and E; X40 is selected from A and E; X43 is selected from A and K; X44 is selected from A, S and E; L in position 45 is present or absent; and P in position 46 is present or absent; and ii) An amino acid sequence which has at least 95% identity to the sequence defined in i), with the provisio that X7 is neither L, E or D
Patent NZ-612504-A (NZ)
Title: Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
Inventor: DAVIS STEVEN R
IPC: A23L33/15
Filed: 2011-12-22
Abstract: Disclosed is the use of a composition comprising at least one human milk oligosaccharide selected from the group consisting of 6’-sialyllactose, 2’-fucosyllactose, and lacto-N-neotetraose in the manufacture of a medicament for the treatment or prevention of an inflammatory condition or disease in an infant, toddler, or child by reducing the incidence of oxidative stress in the infant, toddler, or child. Also disclosed is the use of a composition comprising at least one neutral human milk oligosaccharide and at least one acidic human milk oligosaccharide in the manufacture of a medicament for the treatment or prevention of an inflammatory condition or disease in an infant, toddler, or child by reducing the incidence of oxidative stress in the infant, toddler, or child.
Patent NZ-620034-A (NZ)
Title: Novel microwave assisted flash pyrolysis system and method thereof
Inventor: KASIN KJELL IVAR
IPC: F23M9/00
Filed: 2011-08-01
Abstract: The present disclosure provides a microwave assisted flash pyrolysis system to carry out microwave assisted flash pyrolysis in an industrial scale. The microwave assisted flash pyrolysis system comprises at least one microwave generator; a chamber comprises: at least one feedstock inlet, at least one baffle plate, a microwave-transparent rotating window, and at least one microwave inlet, at least one wet gas outlet, and at least one dry end product outlet. The present disclosure also provides a method using the same system to carry out microwave assisted flash pyrolysis.
Patent NZ-627238-A (NZ)
Title: Stable pharmaceutical composition comprising ethyl eicosapentaenoate
Inventor: MANKU MEHAR
IPC: A61K31/20
Filed: 2010-04-29
Abstract: Dislcosed is the use of eicosapentaenoic acid in the manufacture of a medicament for treating high triglycerides in a subject receiving statin therapy, wherein the medicament is formulated to provide about 1100 mg, about 1650 mg, or about 2200 mg of the eicosapentaenoic acid and not more than about 20% docosahexaenoic acid, by weight of fatty acids present in the medicament. Another use disclosed is the use of eicosapentaenoic acid in the manufacture of a medicament for lowering triglycerides without increasing LDL-C by more than 20% in a subject having triglycerides of at least 500 mg/dl, wherein the medicament is in one or more dosage units and comprises: an amount of eicosapentaenoic acid selected from the group consisting of: about 1100 mg, about 1650 mg, and about 2200 mg, and not more than about 30%, by weight of total fatty acids, docosahexaenoic acid. Also disclosed are pharmaceutical composition comprising at least 95% EPA enclosed in a capsule shell, wherein the composition has a baseline peroxide value not greater than 5 Meq/kg and upon storage of the composition at 25°C and 60% RH for a period of 6 months, the composition has a second peroxide value not greater than 8 Meq/kg. The compositions are useful in the treatment of cardiovascular-related diseases.
Patent NZ-628696-A (NZ)
Title: Improved fungal endophytes
Inventor: JOHNSON RICHARD
IPC: C12R1/645
Filed: 2014-03-06
Abstract: Disclosed is an isolated strain of epichloae fungal endophyte selected from the group consisting of AR3039 (NRRL# 50716), AR3046 (NRRL# 50576), AR3049 (NRRL#50577), AR3050 (NRRL# 50578), AR3064 (NRRL# 50718), AR3067 (NRRL# 50719), AR3068 (NRRL# 50720), AR3073 (NRRL# 50721), AR3074 (NRRL# 50722), AR3076 (NRRL# 50723), and AR3078 (NRRL# 50724), and combinations thereof. Further disclosed is a Secale spp. plant infected with a fungal endophyte wherein Secale spp. is not a natural host of the endophyte, and wherein the plant and endophyte form a stable symbiotic association that allows the plant to progress through a normal life cycle.
Patent NZ-701728-A (NZ)
Title: Rotor blade for a wind power plant
Inventor: BOHLEN THOMAS
IPC: F03D1/06
Filed: 2013-04-05
Abstract: The invention relates to a rotor blade (1) for a wind power plant, comprising a rotor blade root (4) for the connection of the rotor blade (1) to a rotor hub and a rotor blade tip arranged on the side facing away from the rotor blade root (4), as well as a wind power plant comprising such rotor blades. A relative profile thickness (2), which is defined as a ratio of profile thickness (2) to profile depth (3), has a local maximum in a centre region (6) between the rotor blade root and rotor blade tip.
Patent NZ-705156-A (NZ)
Title: Improvements to fishing systems
Inventor: FELTON BENJAMIN THOMAS
IPC: A01K91/18
Filed: 2012-05-14
Abstract: Disclosed is a line hauler (20), a method of fishing using a line hauler (20) and a kitset of parts for use in fishing. The present line hauler (20) addresses the issues encountered with tangling of lines or hooks and prevents the line hauler (20) from being dragged back to shore by wave action and currents. Furthermore, first (21) and second (22) body portions of a main body of the line hauler (20) can be disengaged to accommodate a storage configuration. The line hauler (20) includes a main body and fasteners. The main body comprises first (21) and second (22) body portions. The fastener is a latch (29a) and catch (29b) style fastener which secures the first (21) and second (22) body portions together to provide a main body in an in-use configuration. The fasteners can be disengaged to enable to first (21) and second (22) body portions to be separated into a storage configuration. The line hauler (20) further comprises drive means which includes a propeller and a motor (32). The motor (32) rotates the propeller. The line hauler (20) further comprises a control system to control the operation of the drive means wherein a remote control can wirelessly communicate with the control system.
Patent NZ-713746-A (NZ)
Title: Method of treating disease by auricular anesthesia of cranial nerves
Inventor: CREWS THOMAS
IPC: A61P29/00
Filed: 2014-05-05
Abstract: Methods for treating a variety of diseases that comprises performing auricular anesthesia of the vagus, facial, trigeminal, or glossopharyngeal nerves, or combinations thereof. A pharmaceutical composition is administered to an ear canal of a subject in need of such treatment, the composition including an analgesic and an anesthetic. Compositions useful in the taught methods are also provided.
Patent NZ-715520-A (NZ)
Title: Anti-release protective helmet, in particular for sporting use
Inventor: GOTTI ANGELO
IPC: A42B3/08
Filed: 2014-06-18
Abstract: Protective helmet (10), in particular for sports use, comprising : a shell structure (11) shaped so as to at least partially cover the head of a user and configured to protect it from bangs at the cranium portion substantially starting from the eye arch up to the nuchal area both on top and laterally; and a nape-rest element (12) fixedly connected to said shell structure at the nuchal area of the user; said nape-rest element (12) being constrained to said shell structure (11) in a movable manner between a fitting position of said helmet (10), in which it is in substantial contact with the inner rear wall (14) of said shell structure (11) to allow the occipital protuberance of the cranium to be passed over, and a use position of said helmet (10) in which it is separated from said inner rear wall (14) of said shell structure (11) and in substantial contact with the nuchal area of the user wearing said helmet (10), said helmet (10) comprising a spring element (13) to force said nape-rest element (12) in said use position in which it is separated from said inner rear wall (14) of said shell structure (11) and in substantial contact with the nuchal area of the user wearing said helmet (10).
Patent NZ-721708-A (NZ)
Title: Cutting deck flow control assembly
Inventor: POOLE JAMES R
IPC: A01D34/68
Filed: 2015-01-12
Abstract: Lawn mowers employ rotary cutting blades that must be housed for safety reasons. However, the housing of the mower blades with a cutting deck can also enhance the general mowing experience when it is designed to implement other useful functions like directing grass out of a discharge chute or into a bagging attachment. To improve the air flow characteristics of such cutting decks, it would be desirable to provide a cutting deck that is both sturdy, such as fabricated cutting decks, and also has streamlined airflow characteristics, commonly found in stamped cutting decks. The invention thus provides outdoor power equipment comprising a frame; an engine operably coupled to the frame; and a cutting deck operably coupled to the frame, the cutting deck housing at least a first cutting blade and a second cutting blade, the first and second cutting blades being rotatable responsive to operation of the engine, wherein the cutting deck comprises a weldment comprising a top plate and one or more side plates defining a cutting chamber in which the first and second cutting blades are rotatable responsive to operation of the engine; and a flow control assembly disposed within the cutting chamber and extending away from the top plate to define an airflow channel between the flow control assembly and the one or more side plates, wherein the flow control assembly comprises a first directional changing portion disposed proximate to the first cutting blade and a second directional changing portion disposed proximate to the second cutting blade, the first and second directional changing portions being separated from each other by substantially straight portions of the flow control assembly, wherein the first directional changing portion is passed over only by the first cutting blade and the second directional changing portion is passed over by only the second cutting blade, and both the first and second cutting blades pass over the substantially straight portions between the first and second directional changing portions responsive to rotation of the first and second cutting blades, wherein the flow control assembly comprises a first sidewall portion and a second sidewall portion each of which extend substantially perpendicularly away from the top plate, and wherein the first and second sidewall portions each terminate at their respective ends at corresponding bent portions, the bent portions of the first and second sidewall portions meeting to form the first and second directional portions.
Patent NZ-722752-A (NZ)
Title: Multilayer pvdc barrier heat shrinkable films
Inventor: ZANABONI GIULIANO
IPC: B32B27/34
Filed: 2015-01-15
Abstract: Multilayer barrier heat shrinkable films and flexible containers made therefrom, such as bags, pouches and the like, useful for packaging articles, in particular food items are described. These films are characterized by particular shrinking properties, which provide for tight packages reducing the drip loss from the product packaged therein. Moreover, the bags obtained from such films are endowed with very good optical properties and high abuse resistance. The films comprise: an outer heat-sealable layer (a); one layer (b) comprising one or more aromatic (co)polyester(s) which is not directly adhered to the heat sealable layer (a); and at least one internal gas barrier layer (c) comprising polyvinylidene chloride.